Why MRNA's readout is asymmetric

The thesis

Pipeline option value is being given away at the current multiple.

Device adoption is steepening past the conservative model.

What I'm watching

• label/indication scope
• adoption vs install base
• A clean move through the level I flag below

Positioning

Short on MRNA, Event-driven horizon. Conviction: Medium. Binary events demand basket sizing — never bet the farm on one readout.

Opinion, not investment advice. The author may or may not hold positions discussed.